Product Programs
Contact
- 2600 Stemmons Freeway,
- Suite 176
- Dallas, TX 75207-2107
- Tel: (214) 905-5100
- Fax: (214) 905-5101
This page contains a partial list of Access Pharmaceuticals' publications, presented either in scientific journals or at major scientific conferences. Due to copyright restrictions, we cannot provide copies of journal articles, but links are provided to the Pubmed abstract of the article. Poster presentations are available for download. Click on the link to the right of the publication to view either the abstract or the poster.
RR Allison, R Carmel, DF Ciuba, E Feldman, WM Wisbeck, DP Nowotnik, ST Sonis (2012)
Results from the Prospective, Multi-Institutional, Double-Blind, Sham-Controlled Clinical Trial of MuGardTM for Symptom Control Due to
Mucositis in Chemoradiation-Treated Head and Neck Cancer Patients
Poster presentation at the 2012 MASCC/ISOO Supportive Care in Cancer Symposium,
held on June 28-30 2012 in New York, USA.
MuGard MASCC 2012 poster
A Duckert, I Wildfang, D Riesenbeck, S Friesland, K Gunnarsson, M Collucci, C Maisto, C Dumas (2010)
Management of oral mucositis (OM) with a muco-adhesive oral rinse: European clinical experience
Poster presentation at the 2010 European Society for Medical Oncology (ESMO) Symposium,
held on Oct 8-12 2010 in Milan, Italy.
MuGard ESMO 2010 poster
DP Nowotnik, C Dumas (2010) Clinical Experience wih a Polymer-Based Liquid for the Management of Oral Mucositis.
Poster presentation at the 2010 MASCC/ISOO Supportive Care in Cancer Symposium,
held on June 24-26 2010 in Vancouver, Canada
MuGard MASCC 2010 poster
CM Baud, LE Colon, J
Gerberich, DP Nowotnik, SB Howell (2006) Protection from
Radiation-Induced Oral Mucositis by MuGardTM Oral Rinse A
Clinical Study and in silico Analysis. Poster presentation at the
18th International MASCC/ISOO Supportive Care in Cancer Symposium,
held on June 22-24 2006 in Toronto, Canada.
MuGard™ Poster Presentation
G Russell-Jones, K
McTavish, J McEwan, J Rice, D Nowotnik (2004) Vitamin-mediated
targeting as a potential mechanism to increase drug uptake by tumours.J
Inorg Biochem. 98, 1625-33.
Cobalamin™ Mediated Tumor Targeting Abstract
KB Chalasani, GJ http://www.ncbi.nlm.nih.gov/pubmed/18990064
Russell-Jones, et al (2007) A novel vitamin B(12)-nanosphere
conjugate carrier system for peroral delivery of insulin, J.
Control. Release, 117, 421-429.
Cobalamin™ Mediated Oral Drug Delivery Abstract
GJ Russell-Jones (2004)
Use of targeting agents to increase uptake and localization of drugs to
the intestinal epithelium, J. Drug Target, 12, 113-123.
Cobalamin™ Mediated Oral Drug Delivery Abstract